Despite federal and state initiatives, hospitals and providers still face financial, technical, and privacy hurdles in making patient records truly interoperable.
The requirements could cost drugmakers tens of millions of dollars and are likely to leave boosters largely out of reach for hundreds of millions of Americans this fall.